Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shao, R.
Right arrow Articles by Hung, M.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shao, R.
Right arrow Articles by Hung, M.-C.
[Cancer Research 61, 7413-7416, October 15, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

E1A Inhibition of Radiation-induced NF-{kappa}B Activity through Suppression of IKK Activity and I{kappa}B Degradation, Independent of Akt Activation1

Ruping Shao, Eing Mei Tsai, Kevin Wei, Ryan von Lindern, Yun-Houng Chen, Keishi Makino and Mien-Chie Hung2

Department of Molecular and Cellular Oncology, Breast Cancer Basic Research Program, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Activation of the transcription factor nuclear factor {kappa}B (NF-{kappa}B) has been implicated in the protection of cells from apoptosis. We have shown previously that the adenovirus type 5 E1A sensitizes cells to radiation-induced apoptosis by inhibiting NF-{kappa}B activity. However, the exact mechanism of inhibition is not known. In this study, we compared the activity of inhibitor of nuclear factor-{kappa}B (I{kappa}B) kinase (IKK) and the degradation of I{kappa}B{alpha} in E1A transfectants and parental human cancer cells after ionizing radiation treatment. We found that radiation-induced IKK activity and I{kappa}B{alpha} degradation were inhibited in the E1A transfectants. Recently, Akt has been implicated in NF-{kappa}B activation. To test whether Akt is regulated by E1A and is involved in radiation-induced NF-{kappa}B activity, we examined the phosphorylation status of Akt in the E1A transfectants and parental cells and in irradiated cells. The results indicated that radiation induced Akt phosphorylation and that E1A inhibited basal but not radiation-induced Akt phosphorylation. We additionally examined radiation-induced NF-{kappa}B activity in cells stably transfected with a dominant-negative, inactive Akt and in parental cancer cells treated with a phosphatidylinositol 3-kinase inhibitor, wortmannin. We found that dominant-negative Akt and wortmannin did not block radiation-induced NF-{kappa}B activity. Thus, our results suggest that inhibition of IKK activity and I{kappa}B degradation is the predominant mechanism for E1A-mediated inhibition of radiation-induced NF-{kappa}B activity and that radiation-induced Akt activation cannot be inhibited by E1A and is likely independent of radiation-induced NF-{kappa}B activity.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
K-M Rau, H-Y Kang, T-L Cha, S A Miller, and M-C Hung
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
Endocr. Relat. Cancer, September 1, 2005; 12(3): 511 - 532.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. Shao, D.-F. Lee, Y. Wen, Y. Ding, W. Xia, B. Ping, H. Yagita, B. Spohn, and M.-C. Hung
E1A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis through Enhancement of Caspase Activation
Mol. Cancer Res., April 1, 2005; 3(4): 219 - 226.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. L. Lee, H. S. Lee, J. Jung, S. J. Cho, H.-Y. Chung, W. H. Kim, Y.-W. Jin, C. S. Kim, and S. Y. Nam
Nuclear Factor-{kappa}B Activation Correlates with Better Prognosis and Akt Activation in Human Gastric Cancer
Clin. Cancer Res., April 1, 2005; 11(7): 2518 - 2525.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-P. Lee, D.-I. Tai, S.-L. Tsai, C.-T. Yeh, Y. Chao, S.-D. Lee, and M.-C. Hung
Adenovirus Type 5 E1A Sensitizes Hepatocellular Carcinoma Cells to Gemcitabine
Cancer Res., October 1, 2003; 63(19): 6229 - 6236.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. S. Russell and P. J. Tofilon
Radiation-induced Activation of Nuclear Factor-kappa B Involves Selective Degradation of Plasma Membrane-associated Ikappa Balpha
Mol. Biol. Cell, October 1, 2002; 13(10): 3431 - 3440.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. L. Cook, T. A. Walker, G. S. Worthen, and J. R. Radke
Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha
PNAS, July 23, 2002; 99(15): 9966 - 9971.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.